This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Shock, not elsewhere classified
R18_SHOCK_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
345 |
4. Check minimum number of eventsNone |
345 |
5. Include endpointsNone |
345 |
6. Filter based on genotype QC (FinnGen only) |
345 |
Control definitions (FinnGen only)
- Control exclude
- R18_GENERAL_SYMPTOMS_SIGNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R[5-6]
- Name in latin
- Plaga non alibi classificata
Similar endpoints
↥List of similar endpoints to
Shock, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Condition for Implicit Sepsis (Organ dysfunction codes)
- General symptoms and signs
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 345 | 138 | 207 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.09 |
| Median age at first event (years) | 65.25 | 61.81 | 67.54 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 302
- Matched controls
- 3021
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R57.0
ICD-10 Finland
Cardiogenic shock
+∞
139.7
123
*
R57.9
ICD-10 Finland
Shock, unspecified
+∞
72.9
67
*
R57.1
ICD-10 Finland
Hypovolaemic shock
+∞
71.8
66
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
8.9
55.2
140
267
R57.8
ICD-10 Finland
Other shock
+∞
52.7
49
*
WX872
NOMESCO Finland
Intensive care
12.9
40.5
75
75
N17.9
ICD-10 Finland
Acute renal failure, unspecified
17.4
34.4
55
38
TPH07
NOMESCO Finland
Cathetrisation of artery
6.6
31.5
91
186
A41.9
ICD-10 Finland
Sepsis, unspecified
15.2
29.1
49
38
C03CA01
ATC
furosemide; systemic
4.0
27.7
156
632
R55
ICD-10 Finland
Syncope and collapse
22.7
26.4
38
19
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.9
25.9
80
174
R50.9
ICD-10 Finland
Fever, unspecified
12.4
25.1
46
43
AA1AD
NOMESCO Finland
CT of head and brain
4.1
22.6
105
346
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
4.4
22.0
93
279
TK800
NOMESCO Finland
Hemodialysis
19.3
21.9
33
19
R56.8
ICD-10 Finland
Other and unspecified convulsions
+∞
21.1
20
*
C07AB07
ATC
bisoprolol; oral
3.2
20.6
188
1025
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.0
20.1
59
118
WX892
NOMESCO Finland
Monitored bed care
6.8
19.9
52
89
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.2
19.8
87
268
WX704
NOMESCO Finland
Intubation
6.8
19.0
50
86
I50.9
ICD-10 Finland
Heart failure, unspecified
4.1
18.8
82
250
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.1
18.3
81
249
TPH04
NOMESCO Finland
Cathetrisation of vein
3.7
17.4
90
312
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.3
17.3
110
451
C03DA01
ATC
spironolactone; oral
4.5
17.2
66
176
I25.1
ICD-10 Finland
Atherosclerotic heart disease
3.2
16.9
112
469
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
16.0
108
456
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.3
15.9
43
77
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.2
15.8
102
418
B01AA03
ATC
warfarin; systemic
3.2
15.7
99
398
I50.0
ICD-10 Finland
Congestive heart failure
5.0
15.6
53
124
C09AA05
ATC
ramipril; oral
2.9
14.9
111
498
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
5.2
14.5
46
100
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.1
14.4
47
105
N17.8
ICD-10 Finland
Other acute renal failure
23.7
14.4
20
9
JAH00
NOMESCO Finland
Laparotomy
10.5
14.0
27
28
L04AA06
ATC
mycophenolic acid; systemic
21.3
14.0
20
10
ZX120
NOMESCO Finland
Intravenous
4.7
13.8
49
120
R53
ICD-10 Finland
Malaise and fatigue
4.1
13.2
54
152
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
4.9
13.1
44
102
FXG00
NOMESCO Finland
Insertion and use of IABP
52.4
13.0
15
*
127
Kela drug reimbursment
Transplant complication
21.2
12.6
18
9
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
12.6
103
478
TK810
NOMESCO Finland
Hemofiltration
135.4
12.5
13
*
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
135.4
12.5
13
*
I50.1
ICD-10 Finland
Left ventricular failure
5.3
12.1
37
77
WX882
NOMESCO Finland
High dependency care
9.6
12.0
24
27
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
48.7
12.0
14
*
J15.8
ICD-10 Finland
Other bacterial pneumonia
48.7
12.0
14
*
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
11.2
12.0
22
21
201
Kela drug reimbursment
Chronic cardiac insufficiency
4.9
12.0
40
92
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.0
11.5
48
137
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.9
11.2
47
135
A28
ICPC
Limited function/disability NOS
3.2
11.0
62
225
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.6
11.0
101
496
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
10.8
143
846
WW502
NOMESCO Finland
Autotransfusion
22.4
10.8
15
7
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
9.0
10.7
22
26
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
5.7
10.6
30
57
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
5.1
10.5
33
71
FXE00
NOMESCO Finland
Use of ECLA
113.8
10.5
11
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
7.1
10.4
25
38
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.5
10.3
30
59
R4110
NOMESCO Finland
Physiotherapy
2.5
10.2
96
474
AN1
HP
Coronary angiography
3.1
9.9
58
214
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
7.2
9.8
23
34
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.5
9.8
86
409
205
Kela drug reimbursment
Chronic hypertension
2.3
9.7
115
637
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
103.1
9.5
10
*
I42.0
ICD-10 Finland
Dilated cardiomyopathy
8.7
9.2
19
23
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
12.0
9.2
16
14
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
9.1
65
273
C01BD01
ATC
amiodarone; systemic
7.8
9.1
20
27
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
9.1
38
109
1CX08
NOMESCO Finland
NA
37.9
9.1
11
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.2
9.0
49
170
J01FF01
ATC
clindamycin; systemic
2.4
8.9
87
433
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
9.0
8.9
18
21
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
9.9
8.9
17
18
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.0
8.9
54
205
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
4.3
8.8
32
81
I25.2
ICD-10 Finland
Old myocardial infarction
3.4
8.8
42
135
C10AA01
ATC
simvastatin; oral
2.1
8.8
148
949
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.3
8.7
44
148
H02AB06
ATC
prednisolone; systemic
2.1
8.6
139
873
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
4.5
8.5
29
69
C01DA14
ATC
isosorbide mononitrate; oral
2.5
8.4
71
327
E87.2
ICD-10 Finland
Acidosis
+∞
8.4
8
*
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
+∞
8.4
8
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
8.2
35
102
A02BC02
ATC
pantoprazole; systemic
2.0
8.2
188
1349
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
12.2
8.2
14
12
GBB00
NOMESCO Finland
Tracheostomy
12.2
8.2
14
12
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.2
8.1
42
143
TKC20
NOMESCO Finland
Catheterisation of bladder
3.3
8.1
40
132
JN4AD
NOMESCO Finland
Body CT examination
3.7
8.1
35
104
TQW11
NOMESCO Finland
Vacuum treatment of wound
13.5
7.9
13
10
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.8
7.9
16
19
WX725
NOMESCO Finland
Noninvasive ventilation
5.3
7.9
23
46
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
15.5
7.8
12
8
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.9
7.7
31
86
R51.80
ICD-10 Finland
Headache
4.7
7.7
25
57
A11CC03
ATC
alfacalcidol; systemic
9.2
7.6
15
17
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
8.0
7.5
16
21
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
7.5
42
151
FXL00
NOMESCO Finland
Insertion and use of extra-, para- or intracorporeal VAD
82.0
7.4
8
*
R11
ICD-10 Finland
Nausea and vomiting
4.0
7.4
29
79
B03XA02
ATC
darbepoetin alfa; parenteral
9.7
7.4
14
15
Z94.1
ICD-10 Finland
Heart transplant status
+∞
7.3
7
*
I95.9
ICD-10 Finland
Hypotension, unspecified
16.2
7.3
11
7
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
7.3
31
91
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
7.3
73
365
R4130
NOMESCO Finland
Speech therapy
8.2
7.2
15
19
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.1
7.2
27
71
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
20.6
7.2
10
5
G04BE03
ATC
sildenafil; oral
10.4
7.1
13
13
I21.09
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
7.3
7.1
16
23
C09DX04
ATC
valsartan and sacubitril; oral
14.2
6.9
11
8
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
14.2
6.9
11
8
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
6.9
29
84
I20.90
ICD-10 Finland
Angina pectoris, unspecified
5.3
6.9
20
40
I21.01
ICD-10 Finland
Acute transmural myocardial infarction of anterior wall
6.4
6.9
17
28
PD5BD
NOMESCO Finland
Extensive CT of aorta
9.6
6.9
13
14
JN4BD
NOMESCO Finland
Extensive body CT
2.9
6.8
40
149
D64.9
ICD-10 Finland
Anaemia, unspecified
2.8
6.7
42
162
K72.9
ICD-10 Finland
Hepatic failure, unspecified
23.1
6.7
9
*
Z94.0
ICD-10 Finland
Kidney transplant status
23.1
6.7
9
*
C01AA05
ATC
digoxin; systemic
2.8
6.7
45
180
B01AB05
ATC
enoxaparin; parenteral
2.0
6.6
94
547
J01MA02
ATC
ciprofloxacin; systemic
1.9
6.6
119
759
WX730
NOMESCO Finland
Conventional respirator
7.7
6.5
14
19
R06.0
ICD-10 Finland
Dyspnoea
2.1
6.4
77
416
G72.8
ICD-10 Finland
Other specified myopathies
9.6
6.3
12
13
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
3.3
6.3
30
97
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
18.5
6.3
9
5
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
18.5
6.3
9
5
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.1
6.3
80
445
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.7
6.3
41
164
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
+∞
6.3
6
*
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
27.3
6.3
8
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.6
6.3
17
32
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.4
6.2
28
87
J01MA14
ATC
moxifloxacin; systemic
3.1
6.2
32
110
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.0
6.1
23
61
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.9
6.1
12
14
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.4
6.1
17
33
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.9
6.1
14
21
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.0
6.1
85
489
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
5.0
6.0
18
38
I20.99
ICD-10 Finland
Angina pectoris, unspecified
3.3
6.0
29
95
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
120
200
8.67
74.66
21.0
6.3
11.8
10.6
mmol/l
0.70
115
189
130
280
6.85
62.44
15.1
5.7
1.1
1.1
mmol/l
0.39
124
258
123
262
6.74
59.46
34.4
6.8
12.0
12.2
kpa
0.16
111
252
123
262
6.74
59.46
34.4
6.8
4.8
5.1
kpa
2.07
111
251
122
259
6.74
59.15
34.7
6.9
0.8
1.2
mmol/l
0.32
87
207
77
104
9.24
56.26
35.7
5.2
1.8
1.6
%
0.81
69
98
139
350
5.98
55.85
11.4
2.8
0.8
0.8
mmol/l
0.06
132
329
69
95
8.83
49.36
4.7
1.5
13.4
2.6
ug/l
1.48
62
81
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
58
69
9.90
46.46
9.6
2.3
0.3
0.4
u/ml
0.79
45
34
80
145
6.88
44.53
39.7
7.6
23.3
24.6
mmol/l
1.37
73
136
99
222
5.85
44.21
41.6
7.5
110.2
119.3
g/l
3.30
93
213
115
313
5.01
40.77
4.3
2.1
2.2
2.3
g/l
1.72
109
287
106
296
4.73
35.96
4.4
2.2
20.2
22.5
%
0.76
76
250
129
433
4.16
34.08
8.5
3.1
814.6
482.6
ng/l
0.58
118
354
89
229
4.89
33.21
2.2
1.7
—
—
—
0
0
88
232
4.75
31.77
2.1
1.6
—
—
—
0
0
90
245
4.62
31.16
8.8
3.4
267.0
251.7
u/l
0.28
84
229
82
218
4.62
29.12
7.9
4.0
1.5
1.9
mmol/l
0.38
68
171
68
155
5.22
29.08
2.9
1.5
—
—
—
0
0
103
346
3.82
26.39
2.3
1.6
—
—
—
0
0
27
24
12.12
26.09
10.4
8.9
547.8
127.8
iu/ml
—
5
5
38
56
7.50
25.15
9.0
2.2
234.2
182.3
%
1.94
38
56
51
102
5.69
25.08
2.4
1.5
1.6
1.4
g/l
0.50
42
85
31
36
9.36
24.91
1.3
1.3
—
—
—
0
0
102
357
3.64
24.38
9.4
1.9
33.6
29.6
s
3.00
102
343
28
30
10.07
23.84
2.1
1.3
274.8
98.3
u/ml
—
7
6
30
36
9.03
23.48
1.3
1.3
—
—
—
0
0
74
216
4.09
22.90
2.8
2.3
18.1
8.0
ug/l
1.37
63
187
71
202
4.17
22.74
4.1
2.2
0.2
0.2
g/l
1.96
63
191
86
295
3.55
20.92
19.4
6.3
104.5
104.5
mmol/l
0.04
86
288
202
1131
2.90
20.68
32.9
6.2
1.2
1.2
mmol/l
8.72
182
950
213
1229
2.92
20.56
16.5
5.4
15.2
11.9
umol/l
2.17
206
1153
184
993
2.83
20.01
15.2
4.6
30.9
35.3
g/l
13.84
174
924
130
591
2.93
19.47
3.2
1.9
2.8
3.1
mg/l
0.41
118
497
154
766
2.83
19.47
8.4
3.2
58.3
31.7
u/l
1.01
146
733
140
678
2.79
18.43
4.0
1.8
577.4
262.1
u/l
1.42
132
632
64
196
3.78
18.29
21.0
6.4
2.2
1.4
mmol/l
1.84
57
189
143
705
2.76
18.12
5.9
2.1
64.5
57.8
u/l
0.67
137
650
75
259
3.42
17.85
6.9
2.4
10.9
9.4
umol/l
0.28
67
229
23
30
8.14
16.75
1.8
1.2
235.8
254.0
u/ml
0.09
17
17
46
119
4.31
16.52
26.1
8.0
22.3
24.8
mmol/l
3.15
40
107
17
15
11.87
16.32
1.4
1.0
—
—
—
0
0
23
31
7.88
16.30
1.8
1.2
—
—
—
0
0
170
958
2.53
15.88
4.3
2.3
210.5
146.3
ug/l
1.89
162
880
29
53
5.88
15.52
2.9
1.5
—
—
—
0
0
186
1102
2.49
15.47
9.6
3.9
—
—
—
0
0
220
1409
2.55
15.43
25.3
4.1
7.8
6.8
mmol/l
4.11
207
1307
14
10
14.55
15.12
1.3
1.4
—
—
—
0
0
179
1057
2.44
14.80
32.6
5.2
1.2
1.2
mmol/l
8.35
168
941
181
1089
2.39
14.15
11.4
4.9
61.0
57.3
%
3.41
176
1023
181
1097
2.37
13.81
11.5
5.1
22.8
27.7
%
5.94
174
1020
100
463
2.63
13.78
8.4
1.6
3.1
1.3
mg/l
1.69
87
359
24
44
5.79
12.77
1.3
1.5
—
—
—
0
0
19
29
6.88
12.04
1.1
1.2
—
—
—
0
0
26
56
4.94
11.62
4.2
2.7
1.1
1.0
nmol/l
0.26
21
47
18
27
6.98
11.58
1.1
1.2
—
—
—
0
0
16
8
20.89
11.23
4.1
1.0
87.9
116.1
%
—
16
8
15
19
8.21
11.09
1.5
1.4
—
—
—
0
0
15
21
7.42
10.21
1.1
1.2
—
—
—
0
0
68
303
2.55
9.87
32.9
28.4
1.8
1.4
inr
—
7
36
89
463
2.24
9.08
1.9
1.7
1007.2
1207.3
nmol/l
1.57
73
357
50
200
2.75
8.96
3.2
1.9
29.2
30.7
u/l
0.13
44
168
23
56
4.33
8.86
1.5
1.1
—
—
—
0
0
12
16
7.73
8.46
3.1
1.3
—
—
—
0
0
190
1346
1.92
8.01
14.3
7.8
5.1
4.2
e9/l
3.10
174
1180
123
757
1.97
7.89
8.7
3.0
4625.5
1494.2
ng/l
3.06
117
642
149
979
1.92
7.86
2.5
1.9
86.0
93.8
pmol/l
1.09
91
511
22
58
3.98
7.65
1.2
1.2
—
—
—
0
0
20
50
4.18
7.45
1.5
1.5
—
—
—
0
0
96
556
2.01
7.23
4.5
2.2
—
—
—
0
0
10
13
7.89
7.15
1.4
1.2
—
—
—
0
0
37
143
2.78
7.05
6.5
3.5
0.5
1.6
mmol/l
0.69
24
113
240
1879
1.91
7.01
18.3
6.4
92.7
77.7
u/l
4.43
233
1735
20
53
3.94
6.91
1.5
1.2
250.3
261.5
ug/g
0.08
14
26
13
24
5.59
6.82
1.4
1.2
1.8
2.1
u/ml
—
6
8
119
771
1.83
6.26
6.4
3.2
2.3
2.3
mmol/l
3.83
107
666
69
375
2.05
6.11
2.9
2.7
3.5
1.2
e6/l
0.65
38
223
9
6
15.35
5.93
1.1
1.2
—
—
—
0
0
15
36
4.31
5.88
1.2
1.3
—
—
—
0
0
15
36
4.31
5.88
1.2
1.3
—
—
—
0
0
10
9
11.40
5.83
1.2
1.0
—
—
—
0
0
129
875
1.76
5.73
4.7
2.9
—
—
—
0
0
17
46
3.84
5.71
1.3
1.5
—
—
—
0
0
10
17
6.03
5.66
1.2
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
7
13.15
5.61
3.0
1.0
149.7
139.3
%
—
9
7
29
112
2.74
5.55
4.3
3.2
0.8
0.6
%
1.11
29
107
103
664
1.79
5.39
4.6
2.9
0.5
0.5
e6/l
0.00
82
504
11
22
5.13
5.29
1.7
1.8
—
—
—
0
0
11
22
5.13
5.29
5.5
2.5
4.5
4.5
e9/l
0.03
11
22
22
75
3.07
5.24
3.5
2.1
3.1
3.1
g/l
0.04
16
57
5
0
+∞
5.22
1.2
0.0
82.0
—
umol/l
—
5
0
32
135
2.51
5.15
1.7
1.5
—
—
—
0
0
13
31
4.32
5.13
1.5
1.2
3396.4
46822.7
e6/l
—
7
21
13
31
4.32
5.13
1.4
1.3
—
—
—
0
0
8
6
13.61
5.10
1.1
1.2
—
—
—
0
0
11
23
4.91
5.05
6.5
2.7
59.9
58.5
%
0.09
11
23
15
41
3.78
4.98
3.9
1.9
16.2
15.7
%
—
10
19
13
33
4.05
4.75
1.2
1.1
—
—
—
0
0
21
74
2.96
4.74
3.7
1.9
11.0
10.3
g/l
0.24
16
64
28
118
2.49
4.53
1.8
1.3
—
—
—
0
0
22
82
2.80
4.51
3.5
2.0
7.6
7.2
g/l
0.46
16
61
22
82
2.80
4.51
3.5
2.0
3.9
3.8
g/l
0.02
16
56
22
82
2.80
4.51
3.5
2.0
—
—
—
0
0
10
23
4.45
4.11
1.0
1.1
—
—
—
0
0
66
404
1.78
4.02
2.7
2.6
1.1
1.1
e6/l
0.07
34
252
131
961
1.59
4.01
5.7
3.2
668.1
85.4
ng/l
1.19
103
689
91
615
1.65
3.87
4.9
2.5
3034.2
8519.0
umol/l
0.87
86
530
124
907
1.57
3.80
3.6
2.1
71.7
76.3
nmol/l
1.02
112
797
6
5
12.18
3.77
1.5
1.0
—
—
—
0
0
15
50
3.09
3.73
3.7
1.3
0.6
0.8
nmol/l
1.04
15
45
46
266
1.84
3.37
4.3
4.6
54.6
10.3
ug/l
0.40
40
222
8
14
5.82
3.36
1.4
1.6
—
—
—
0
0
18
71
2.62
3.35
2.3
2.8
—
—
—
0
0
8
15
5.43
3.21
1.0
1.1
—
—
—
0
0
12
39
3.15
3.12
1.3
1.4
—
—
—
0
0
6
8
7.61
3.06
2.0
1.1
—
—
—
0
0
213
1804
1.47
3.01
5.9
3.6
20.2
11.9
mm/h
8.29
205
1642
12
40
3.07
3.00
1.0
1.2
10.3
11.6
u/l
—
7
33
6
9
6.76
2.88
3.3
1.2
—
—
—
0
0
9
23
3.99
2.79
1.8
1.1
85.2
115.3
%
—
9
23
185
1540
1.43
2.77
7.5
3.0
76.1
49.7
u/l
2.70
171
1433
6
186
0.31
2.76
2.0
1.8
—
—
—
0
0
5
6
8.43
2.76
1.6
1.0
1586.6
769.3
u/ml
—
5
6
6
10
6.08
2.71
1.0
1.0
1.7
1.8
mmol/l
—
6
10
8
19
4.28
2.69
1.6
1.1
73.8
90.8
%
—
8
19
206
2346
0.70
2.67
38.1
11.6
71.3
78.0
ml/min/173m2
3.21
184
1895
15
62
2.48
2.57
1.1
1.1
—
20.0
—
0
5
220
2467
0.70
2.50
5.4
4.5
1.3
1.4
mmol/l
4.86
205
2242
7
16
4.44
2.48
1.7
1.1
—
—
—
0
0
46
688
0.62
2.42
2.7
3.1
0.6
0.8
ug/l
1.74
30
463
5
8
6.32
2.38
1.0
1.1
—
—
—
0
0
145
1192
1.37
2.18
5.0
3.4
0.0
0.0
estimate
0.00
22
199
72
523
1.48
2.16
4.4
3.7
1.0
1.0
kg/l
0.66
17
85
6
14
4.34
2.16
1.5
1.6
—
—
—
0
0
224
2483
0.72
2.15
5.5
4.5
4.2
4.6
mmol/l
6.35
209
2282
143
1175
1.37
2.15
4.7
3.3
0.0
0.0
estimate
0.00
21
208
70
510
1.47
2.07
2.0
1.8
467.9
13380703.4
pmol/l
0.50
60
426
60
425
1.50
2.04
3.1
2.9
2.5
2.5
mmol/l
0.79
50
373
8
27
3.01
1.95
1.6
1.1
—
—
—
0
0
5
11
4.59
1.95
1.0
1.1
—
—
—
0
0
5
11
4.59
1.95
1.4
1.1
—
—
—
0
0
38
247
1.61
1.89
2.5
1.7
1.7
1.4
%
1.25
30
215
231
2527
0.74
1.83
6.0
5.1
2.3
2.7
mmol/l
7.79
215
2300
7
24
2.95
1.73
1.0
1.0
—
—
—
0
0
0
48
0.00
1.71
0.0
1.6
—
—
—
0
0
38
254
1.56
1.69
6.0
3.0
—
—
—
0
0
10
42
2.42
1.69
2.3
1.4
—
—
—
0
0
140
1180
1.31
1.68
6.4
4.6
0.0
0.0
estimate
0.00
20
206
6
19
3.19
1.67
1.2
1.9
—
—
—
0
0
5
14
3.61
1.62
1.2
1.1
—
—
—
0
0
5
14
3.61
1.62
1.2
1.1
—
—
—
0
0
101
818
1.33
1.59
4.4
4.0
6.0
11.4
mg/mmol
1.25
76
530
201
1790
1.29
1.56
4.4
3.4
14.8
15.0
pmol/l
0.46
185
1580
5
15
3.37
1.53
1.2
1.1
—
—
—
0
0
5
15
3.37
1.53
1.2
1.1
—
—
—
0
0
5
15
3.37
1.53
1.2
1.1
—
—
—
0
0
218
2381
0.77
1.51
5.6
4.0
1.3
1.3
mmol/l
0.59
203
2150
9
39
2.34
1.44
1.2
1.2
—
—
—
0
0
9
41
2.23
1.38
1.3
1.1
—
—
—
0
0
5
17
2.97
1.36
3.4
2.4
14.1
13.3
%
—
5
17
6
24
2.53
1.31
2.8
3.7
—
—
—
0
0
5
20
2.52
1.15
1.0
1.2
—
—
—
0
0
5
20
2.52
1.15
1.6
1.4
—
—
—
0
0
242
2252
1.25
1.10
58.2
13.7
34.2
39.9
%
7.67
157
1585
57
450
1.32
1.08
1.3
1.2
1.0
0.8
u/ml
0.19
11
120
22
318
0.67
1.02
15.6
6.9
—
—
—
0
0
102
1177
0.81
1.00
4.2
5.0
3.3
2.5
ug/l
0.31
94
1042
9
50
1.82
0.97
1.8
1.2
—
—
—
0
0
81
954
0.80
0.96
3.6
4.4
22.6
21.7
%
0.15
31
469
17
111
1.56
0.89
1.2
1.2
—
—
—
0
0
232
2460
0.83
0.89
5.1
4.6
6.3
6.0
mmol/l
2.35
215
2219
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
0
27
0.00
0.77
0.0
1.5
—
—
—
0
0
0
27
0.00
0.77
0.0
1.4
—
—
—
0
0
0
27
0.00
0.77
0.0
1.5
—
—
—
0
0
0
28
0.00
0.76
0.0
1.8
—
—
—
0
0
10
159
0.62
0.74
1.6
2.0
—
—
—
0
0
9
143
0.62
0.71
1.6
2.0
—
—
—
0
0
11
69
1.61
0.69
1.2
1.1
—
—
—
0
0
9
59
1.54
0.69
1.1
1.5
—
—
—
0
0
106
945
1.18
0.68
5.0
3.4
—
—
—
0
0
261
2500
1.18
0.64
46.1
11.8
35.5
26.8
mg/l
3.49
246
1931
11
71
1.57
0.63
1.2
1.1
—
—
—
0
0
43
355
1.24
0.61
1.3
1.2
2.0
13.4
u/ml
2.33
13
142
225
2361
0.86
0.61
8.1
5.9
42.5
40.3
mmol/mol
2.14
213
2186
0
23
0.00
0.58
0.0
1.6
—
—
—
0
0
45
376
1.23
0.58
1.2
1.2
32.4
49.4
iu/ml
0.49
12
125
19
245
0.76
0.50
1.3
1.5
—
—
—
0
0
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
5
34
1.48
0.40
1.2
1.4
—
—
—
0
0
11
85
1.30
0.28
1.8
1.5
—
—
—
0
0
9
74
1.22
0.25
2.8
1.5
—
—
—
0
0
12
96
1.26
0.25
1.3
2.6
96.1
44.5
u/ml
0.31
12
90
13
107
1.22
0.22
11.5
3.7
23.5
24.9
mmol/l
0.73
13
100
12
98
1.23
0.21
1.7
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
52
1.16
0.19
1.3
1.3
—
—
—
0
0
140
1357
1.05
0.16
3.3
2.6
—
—
—
0
0
34
318
1.08
0.11
1.4
1.4
—
—
—
0
0
5
61
0.82
0.08
1.0
1.8
118.4
235.6
pmol/l
—
5
56
7
67
1.05
0.08
2.0
1.2
—
—
—
0
0
6
71
0.84
0.07
1.8
1.8
—
—
—
0
0
12
108
1.12
0.07
1.1
1.0
—
—
—
0
0
224
2217
1.03
0.07
5.5
4.2
2.1
2.0
mu/l
0.52
211
1967
13
120
1.09
0.05
1.1
1.2
343.2
128.1
iu/ml
—
6
42
18
190
0.94
0.04
4.2
2.7
52.9
64.4
ml/min/173m2
0.89
12
65
64
632
1.02
0.01
5.7
3.5
0.0
0.0
estimate
0.00
19
199
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
5
57
0.88
0.00
1.8
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
3.3
—
0
8
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_SHOCK_NOT_ELSEW_CLASSIFIED – Shock, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).